Thompson Davis & Co., Inc. Merck & Co., Inc. Transaction History

Thompson Davis & Co., Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	BUY	$108.61 - $118.38 $200,928 - $219,003	1,850 New	1,850 $213,000
Q4 2022 Feb 06, 2023	BUY	$87.44 - $112.11 $404,410 - $518,508	4,625 New	4,625 $513,000
Q2 2022 Aug 02, 2022	BUY	$83.49 - $94.64 $1.52 Million - $1.72 Million	18,210 New	18,210 $1.66 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $18,070 - $22,635	-250 Closed	0 $0
Q1 2018 May 02, 2018	SELL	$50.96 - $59.23 $7,644 - $8,884	-150 Reduced 37.5%	250 $14,000
Q4 2017 Feb 05, 2018	SELL	$51.62 - $61.64 $55,181 - $65,893	-1,069 Reduced 72.77%	400 $23,000
Q3 2017 Oct 30, 2017	SELL	$58.67 - $63.13 $166,857 - $179,541	-2,844 Reduced 65.94%	1,469 $94,000
Q2 2017 Aug 10, 2017	BUY	N/A	4,313	4,313 $276,000

3,873

1.89B

16.1M

13.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $219B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.